Sign Up
Stories
BioNTech Faces Securities Lawsuit
Share
Alleged Investor Misconduct Lawsuits Ale...
AlloVir Class Action Lawsuit Filed
Assertio Lawsuit Amid Generic Drug Appro...
Altimmune Faces Investor Investigation
Amylyx Pharmaceuticals Faces Lawsuit
BioNTech Investors Alert: Lawsuit Potent...
Overview
API
Bronstein, Gewirtz & Grossman LLC files a class action lawsuit against BioNTech SE for alleged false statements on Comirnaty's demand and inventory risks.
Ask a question
Could this case influence regulations regarding vaccine-related disclosures in the future?
How might this lawsuit impact BioNTech's reputation and stock performance?
What measures can companies take to ensure transparent communication with investors?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Coverage